SMWB vs SEMR vs BRZE vs SPNS vs DSGN

For growth investors, Braze, Inc.

(BRZE) is the stronger pick with 24. 4% revenue growth year-over-year, versus 5. 4% for Sapiens International Corporation N. V. (SPNS). Sapiens International Corporation N. V. (SPNS) offers the better valuation at 33. 7x trailing P/E (27. 9x forward), making it the more compelling value choice. Analysts rate Similarweb Ltd. (SMWB) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Similarweb Ltd.

is actually cheaper at 25. 7x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Sapiens International Corporation N.

V. (SPNS) delivered a total return of +67. 6%, compared to -80. 1% for Similarweb Ltd. (SMWB). Over 10 years, the gap is even starker: SPNS returned +290. 8% versus SMWB's -80. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Sapiens International Corporation N.

V. (SPNS) is the lower-risk stock at 0. 51β versus Similarweb Ltd. 's 1. 79β — meaning SMWB is approximately 254% more volatile than SPNS relative to the S&P 500. On balance sheet safety, Design Therapeutics, Inc. (DSGN) carries a lower debt/equity ratio of 0% versus 186% for Similarweb Ltd. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Braze, Inc.

(BRZE) is pulling ahead at 24. 4% versus 5. 4% for Sapiens International Corporation N. V. (SPNS). On earnings-per-share growth, the picture is similar: Sapiens International Corporation N. V. grew EPS 15. 2% year-over-year, compared to -335. 1% for Semrush Holdings, Inc.. Over a 3-year CAGR, BRZE leads at 27. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Sapiens International Corporation N.

V. (SPNS) is the more profitable company, earning 13. 3% net margin versus -17. 8% for Braze, Inc. — meaning it keeps 13. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SPNS leads at 16. 8% versus -19. 6% for BRZE. At the gross margin level — before operating expenses — SEMR leads at 80. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Similarweb Ltd.

(SMWB) trades at 25. 7x forward P/E versus 37. 2x for Braze, Inc. — 11. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DSGN: 67. 6% to $17. 50.

In this comparison, SPNS (1.

3% yield) pays a dividend. SMWB, SEMR, BRZE, DSGN do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Sapiens International Corporation N.

V. (SPNS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 51), 1. 3% yield, +290. 8% 10Y return). Similarweb Ltd. (SMWB) carries a higher beta of 1. 79 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SPNS: +290. 8%, SMWB: -80. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SMWB (Communication Services) and SEMR (Technology) and BRZE (Technology) and SPNS (Technology) and DSGN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SMWB is a small-cap quality compounder stock; SEMR is a small-cap high-growth stock; BRZE is a small-cap high-growth stock; SPNS is a small-cap quality compounder stock; DSGN is a small-cap quality compounder stock. SPNS pays a dividend while SMWB, SEMR, BRZE, DSGN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.